Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:20 PM
Ignite Modification Date:
2025-12-24 @ 2:20 PM
NCT ID:
NCT04923295
Eligibility Criteria:
Inclusion Criteria:
* The research targets patients on peritoneal dialysis with average and high transport status documented by Peritoneal Equilibrium Transport Test (PET test) in Najah National University Hospital.
Exclusion Criteria:
1. Patients less than 18 years
2. An episode of Peritonitis in less than three months
3. History of recurrent hypoglycemia ( more than two episodes during one month prior to enrollment in the study)
4. Liver disease: Hepatic impairment aspartate transaminase \[AST\] or alanine transaminase \[ALT\] \>3x the upper limit of normal \[ULN\]; or total bilirubin \>2x ULN at time of enrolment)
5. Any allergic reaction to dapagliflozin
6. Type I DM
7. Pregnancy or women who are breast-feeding
8. Symptomatic hypotension or a mean arterial pressure (MAP) less than 60 mmHg
9. MI, unstable angina, stroke, or transient ischemic attack (TIA) within 12 weeks before enrolment
10. Active malignancy requiring treatment at the time of visit -
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04923295
Study Brief:
Protocol Section:
NCT04923295